FDA Orders Label Change for TNF-Alpha Blocker Drugs to Warn Bacterial Infection Risk
By Amy Tudor, Ph.D.News ProducerHealthCentralOfficials with the U.S. Food and Drug Administration (FDA) have announced that they are placing a boxed warning on the labels of all tumor necrosis factor alpha (TNF-alpha) inhibitors that will warn consumers of the risk of infection from Legionella and Listeria, two types of bacteria. TNF-alpha... Read more

